Access to duty free inputs for non infringing pharmaceutical manufacturing now limited to manufacturer exporters under amended advance authorisation. Amendment restricts the new advance authorisation facility for pharmaceutical products made through a Non Infringing process to manufacturer exporters only, revising paragraph 4.1.3 to maintain general authorisation rules for physical exports, intermediate supplies, specified category supplies, and stores, while introducing a Handbook of Procedures provision to allow input access based on actuals when required inputs or quantities diverge from Standard Input Output Norms or adhoc norms.